Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Opioid users' willingness to receive prolonged-release buprenorphine depot injections for opioid use disorder.

Tompkins CNE, Neale J, Strang J.

J Subst Abuse Treat. 2019 Sep;104:64-71. doi: 10.1016/j.jsat.2019.06.007. Epub 2019 Jun 9.

2.

Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences.

Neale J, Tompkins CNE, Strang J.

Drug Alcohol Rev. 2019 Jul;38(5):510-518. doi: 10.1111/dar.12939. Epub 2019 May 26.

3.
4.

Factors influencing recruitment to a randomised placebo-controlled trial of oral naltrexone and extended release implant naltrexone: Qualitative study.

Tompkins CNE, Neale J, Marsden J, Strang J.

J Subst Abuse Treat. 2019 Apr;99:52-60. doi: 10.1016/j.jsat.2019.01.012. Epub 2019 Jan 16.

PMID:
30797394
5.

Implementing and delivering personalised budgets for drug and alcohol users: A narrative systematic review.

Tompkins CNE, Parkman T, Pothecary JC.

Health Soc Care Community. 2019 Jan;27(1):68-81. doi: 10.1111/hsc.12633. Epub 2018 Jul 30. Review.

PMID:
30062705
6.

Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making.

Neale J, Tompkins CNE, McDonald R, Strang J.

Exp Clin Psychopharmacol. 2018 Dec;26(6):570-581. doi: 10.1037/pha0000217. Epub 2018 Jul 23.

PMID:
30035579
7.

Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin.

Neale J, Tompkins CNE, McDonald R, Strang J.

Drug Alcohol Depend. 2018 Aug 1;189:1-7. doi: 10.1016/j.drugalcdep.2018.03.057. Epub 2018 May 25.

8.

Building on feminist achievements to enhance choice for women seeking treatment.

Neale J, Tompkins CNE, Marshall AD, Treloar C, Strang J.

Addiction. 2018 Jun;113(6):1001-1002. doi: 10.1111/add.14226. No abstract available.

PMID:
29732702
9.

Do women with complex alcohol and other drug use histories want women-only residential treatment?

Neale J, Tompkins CNE, Marshall AD, Treloar C, Strang J.

Addiction. 2018 Jun;113(6):989-997. doi: 10.1111/add.14131. Epub 2018 Jan 24.

10.

Improving recruitment to pharmacological trials for illicit opioid use: findings from a qualitative focus group study.

Neale J, Tompkins CNE, McDonald R, Strang J.

Addiction. 2018 Jun;113(6):1066-1076. doi: 10.1111/add.14163. Epub 2018 Feb 21.

11.

Qualitative exploration of relationships between peers in residential addiction treatment.

Neale J, Tompkins CNE, Strang J.

Health Soc Care Community. 2018 Jan;26(1):e39-e46. doi: 10.1111/hsc.12472. Epub 2017 Jul 5.

PMID:
28681464
12.

Associations between injecting illicit drugs into the femoral vein and deep vein thrombosis: A case control study.

Wright NM, Allgar V, Tompkins CN.

Drug Alcohol Rev. 2016 Sep;35(5):605-10. doi: 10.1111/dar.12359. Epub 2015 Dec 7.

PMID:
26644314
13.

Qualitative evaluation of a novel contingency management-related intervention for patients receiving supervised injectable opioid treatment.

Neale J, Tompkins CN, Strang J.

Addiction. 2016 Apr;111(4):665-74. doi: 10.1111/add.13212. Epub 2015 Dec 17.

PMID:
26498274
14.

Injecting drug use in prison: prevalence and implications for needle exchange policy.

Wright NM, Tompkins CN, Farragher TM.

Int J Prison Health. 2015;11(1):17-29. doi: 10.1108/IJPH-09-2014-0032.

PMID:
25751704
15.

Exploring motivations to stop injecting in English prisons: qualitative research with former male prisoners.

Tompkins CN.

Int J Prison Health. 2013;9(2):68-81. doi: 10.1108/17449201311326943.

PMID:
25758439
16.

Cross examination of clinicians at coroners' inquests following deaths in custody.

Wright N, Tompkins CN, Mohammed Z.

Int J Prison Health. 2012;8(3-4):92-8. doi: 10.1108/17449201211284969.

PMID:
25758143
17.

Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.

Wright NM, Sheard L, Adams CE, Rushforth BJ, Harrison W, Bound N, Hart R, Tompkins CN.

Br J Gen Pract. 2011 Dec;61(593):e772-80. doi: 10.3399/bjgp11X613106.

18.
19.

The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification.

Sheard L, Wright NM, El-Sayeh HG, Adams CE, Li R, Tompkins CN.

Subst Abuse Treat Prev Policy. 2009 Feb 5;4:1. doi: 10.1186/1747-597X-4-1.

20.

Exploring prison buprenorphine misuse in the United Kingdom: a qualitative study of former prisoners.

Tompkins CN, Wright NM, Waterman MG, Sheard L.

Int J Prison Health. 2009;5(2):71-87. doi: 10.1080/17449200902880482.

PMID:
25759139
21.

Factors that help injecting drug users to access and benefit from services: A qualitative study.

Neale J, Sheard L, Tompkins CN.

Subst Abuse Treat Prev Policy. 2007 Oct 30;2:31.

22.

Is peer injecting a form of intimate partner abuse? A qualitative study of the experiences of women drug users.

Wright NM, Tompkins CN, Sheard L.

Health Soc Care Community. 2007 Sep;15(5):417-25.

PMID:
17685987
24.

Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial.

Wright NM, Sheard L, Tompkins CN, Adams CE, Allgar VL, Oldham NS.

BMC Fam Pract. 2007 Jan 8;8:3.

26.
27.

How can health services effectively meet the health needs of homeless people?

Wright NM, Tompkins CN.

Br J Gen Pract. 2006 Apr;56(525):286-93. Review.

28.

Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study.

Tompkins CN, Wright NM, Jones L.

Br J Gen Pract. 2005 Apr;55(513):263-8.

29.

Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C.

Wright NM, Tompkins CN, Jones L.

Health Soc Care Community. 2005 Jan;13(1):75-83.

PMID:
15717909
31.

Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis.

Wright NM, Roberts AJ, Allgar VL, Tompkins CN, Greenwood DC, Laurence G.

Br J Gen Pract. 2004 May;54(502):370-3.

32.

Homelessness and health: what can be done in general practice?

Wright NM, Tompkins CN, Oldham NS, Kay DJ.

J R Soc Med. 2004 Apr;97(4):170-3. No abstract available.

33.

Abusive behaviour experienced by primary care receptionists: a cross-sectional survey.

Dixon CA, Tompkins CN, Allgar VL, Wright NM.

Fam Pract. 2004 Apr;21(2):137-9.

PMID:
15020379
34.

Supervised injecting centres.

Wright NM, Tompkins CN.

BMJ. 2004 Jan 10;328(7431):100-2. No abstract available.

35.

Managing violence in primary care: an evidence-based approach.

Wright NM, Dixon CA, Tompkins CN.

Br J Gen Pract. 2003 Jul;53(492):557-62. Review.

36.

Associations between migrancy, health and homelessness: a cross-sectional study.

Tompkins CN, Wright NM, Sheard L, Allgar VL.

Health Soc Care Community. 2003 Sep;11(5):446-52.

PMID:
14498842
37.

Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users.

Wright NM, Campbell TL, Tompkins CN.

Commun Dis Public Health. 2002 Dec;5(4):324-6.

PMID:
12564251

Supplemental Content

Loading ...
Support Center